Highline Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-436,000	Closed	-$52M	–	39
2019 Q1	$52M	Buy	436,000 +311,723	+251%	+$37.2M	3.27%	13
2018 Q4	$13.6M	Buy	+124,277	New	+$13.6M	0.91%	26